UNSPSC 51292104: Maprotiline

This classification denotes an antidepressant agent with the molecular formula C20H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2U1W68TROF, chemically known as 9,10-ethanoanthracene-9(10h)-propylamine, n-methyl- but generally known as maprotiline, which bears US NIH Compound Identifier 4011. European Medicines Agency schedules Maprotiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08647MIG.

UNSPSC 51292104 Maprotiline (Commodity) represents pharmaceutical products, though recent state and local procurement activity under this code shows minimal relevant buying. The single recent solicitation tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—does not align with maprotiline procurement; naloxone is an opioid antagonist used in overdose response, while maprotiline is a tricyclic antidepressant. State and local governments rarely issue formal competitive solicitations for maprotiline as a standalone line item, as psychiatric and neurologic medications typically flow through established pharmacy benefit agreements, group purchasing organization (GPO) contracts, or standing health department formularies rather than discrete IFB or RFP cycles.

The Seminole County opportunity (IFB 60459723LAS, response due July 26, 2023) was a narrowly scoped health and safety procurement with quarterly deliveries to a single county location, requiring E-Verify compliance and drug-free workplace certification, with a three-month probationary termination clause. Because this solicitation is mislabeled or unrelated to the code's actual scope, the data provides no reliable signal about current maprotiline buying patterns, geographic concentration, or repeat-buyer activity among state and local jurisdictions. Firms pursuing pharmaceutical commodity codes should focus on actively posted opportunities in their market rather than relying on this code's recent record.